Drugs / "Neo-Bladder" Construct
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05054790 | Dec 2026 → Dec 2027 expected | low compliance bladder | Wake Forest University Health Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | "Neo-Bladder" Construct | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05054790 ↗ |
| Modality | Cell therapy | “autologous urinary bladder smooth muscle and urothelial cells will be procured and expanded ex vivo” NCT05054790 ↗ |